OMGA – omega therapeutics, inc. (US:NASDAQ)
Stock Stats
News
UPDATE 1-Novo Nordisk ties up with Metaphore to develop new obesity drugs [Yahoo! Finance]
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers
Omega Therapeutics, Inc. (NASDAQ: OMGA) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $7.00 price target on the stock.
Omega Therapeutics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line [Yahoo! Finance]
Omega Therapeutics, Inc. (NASDAQ: OMGA) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $12.00 price target on the stock.
Form 10-Q Omega Therapeutics, Inc. For: Mar 31
Form 8-K Omega Therapeutics, Inc. For: May 06
Form DEFA14A Omega Therapeutics, Inc.
Form DEF 14A Omega Therapeutics, Inc. For: Jun 20
Form PRE 14A Omega Therapeutics, Inc. For: Jun 20
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.